New research has found Horopito extract, a New Zealand plant which has
been in existence for around 65 million years, to be very effective
against recurrent vaginal thrush.
While around 75% of women will suffer from thrush at some stage of their
life 45% will have two or more episodes annually and approximately 5%
are diagnosed with chronic and recurrent infections.
The research, undertaken by ReGenera Research Group, Milan and the
University of Milan, Italy, assessed the clinical efficacy of Kolorex®
softgels (made from a patented extract of the Horopito plant) compared
to a synthetic antifungal drug, in the treatment of thrush. The results
showed Kolorex® softgels to be more effective than pharmaceutical
antifungal drug, Itraconazole.
While 85% of the group taking the pharmaceutical synthetic drug were
thrush free after two years, 91% of the group taking Kolorex® sofgels
were not only thrush free but had less side effects and a significantly
lower relapse rate (22 people in the Kolorex® group compared to 39
relapses in the pharmaceutical group.)
Candida affects a huge number of people and once entrenched in the
system is extremely difficult to remove. Up until now recurrent thrush
sufferers have not had a lot of choice when trying to reduce or
eradicate their symptoms.
The randomised study involved 122 women (aged 22-63 years) with a
history of at least four proven episodes of thrush in the prior 12
months. Participants were put into two groups with comparable age and
previous gynaecological procedures including birth. The two groups took
either two Kolorex® softgels or the pharmaceutical antifungal drug for
one week, every month, for two years.
Kolorex® products were developed by Forest Herbs Research in Nelson, New
Zealand and have been on the market since 1993. A number of clinical
studies over the past 15 years have repeatedly shown Kolorex® to have a
high degree of efficacy in treating many forms of Candida including
vaginal, oral and intestinal thrush and other fungal diseases.
Prophylactic strategies in recurrent vulvovaginal candidiasis: A
two year study testing a phytonutrient vs ItraconazolePublished:
Journal of Biological Regulators & Homeostatic Agents, Vol 27, no. 3,
For further information: www.kolorex.com
[ Back To NFVZone's Homepage ]